P-46 Integrated Transcriptomics and the Exploration of Cancer-Promoting Genes CDKN3 in Esophageal Squamous Cell Cancer

Y. Pan,W. Wang,H. Chen,R. Yu,J. Pu,Y. Liu

DOI: https://doi.org/10.1016/j.annonc.2021.05.101

IF: 51.769

2021-01-01

Annals of Oncology

Abstract:The aims of the present study were to explore the critical genes related to the development of ESCC by integrated transcriptomics and to investigate the clinical significance by experimental validation. The datasets of protein-coding gene expression which are involved in ESCC were downloaded from the GEO database. The “Robustrankaggreg” package was used for data integration, and the different expression genes (DEGs) were identified based the cut-off criteria as follows: adjust p-value < 0.05, |Log2 fold change (FC)| ≥ 1.5; The protein expression of seed gene in 184 cases of primary ESCC were detected by immunohistochemistry; The relationship between the expression level of seed genes and clinical significance were analyzed. A total of 244 DEGs were identified by comparing gene expression patterns between ESCC patients and the controls based on integrating dataset of GSE77861, GSE77861, GSE100942, GSE26886, GSE17351, GSE38129, GSE33426, GSE20347 and GSE23400; The CDKN3 were identified as the seed gene of top cluster by use of PPI network and plug-in MCODE; The level of CDKN3 mRNA was significantly increased in ESCC patients compared to controls. The positive expression rate of CDKN3 protein in ESCC tissue samples was 32.0% and 61.4% in control, respectively, and differences were statistically significant. There was a significant correlation between the expression level of CDKN3 and lymph node metastasis or clinical staging of ESCC patients. Integrated transcriptomics is an efficient approach to system biology. By this procedure, our study improved the understanding of the transcriptome status of ESCC.